<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>MedWorm Tags: generalized</title>
        <description>MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'generalized'.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=%22generalized%22&t=%22generalized%22&r=Exact&o=d&f=tag]]></link>
        <lastBuildDate>Sat, 03 Sep 2011 02:14:09 +0100</lastBuildDate>
        <item>
            <title>A Most Frustrating Press Release</title>
            <link>http://www.medworm.com/index.php?rid=4560246&amp;cid=t_189691_87_f&amp;fid=36438&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FCato-at-liberty%2F%7E3%2FcHutqMPA_KY%2F</link>
            <description>By Sallie JamesMy colleagues and I see many questionable quotes and policy pronouncements from members of Congress, but one crossed my desk recently that really pushes the envelope.
Senator Jeff Sessions (R -AL) -- he who caused some important trade policies to expire in December -- is attempting to &quot;right&quot; that wrong by introducing new legislation (S. 433) to reinstate the policies. Essentially, he is trying to succeed where others (thankfully) failed, i.e., to carve-out legislatively certain products (sleeping bags) made in his state. In so doing, however, he filled his March 2 press release with a retinue of half-truths, disingenuous mis-interpretations and damaging dog-whistles.  Let's examine them one at a time, shall we? (All emphases are mine.)

WASHINGTON¬—U.S. Senator Je...</description>
            <author>Cato-at-liberty</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4560246</comments>
            <pubDate>Mon, 07 Mar 2011 17:14:02 +0100</pubDate>
            <guid isPermaLink="false">4560246</guid>        </item>
        <item>
            <title>Eternal Vigilance Needed on Trade Carve-Outs</title>
            <link>http://www.medworm.com/index.php?rid=4482744&amp;cid=t_189691_87_f&amp;fid=36438&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FCato-at-liberty%2F%7E3%2F0xyyNavTAKM%2F</link>
            <description>By Sallie JamesA bill that would have set a troubling precedent indeed was killed in the Senate last week. I've written previously about the Trade Adjustment Assistance program, and its fate has been tied up with the Generalized System of Preferences, a scheme by which certain developing countries gain duty-free access to the U.S. market for many of their goods. Congress was trying -- and failed -- to pass an extension of the programs together, along with the Andean Trade Preference Act.
Well, in an effort to extend for eighteen months the stimulus-enhanced TAA program (they were less fulsome in their enthusiasm for the other part of the bill; the barrier-reducing ATPA), Senators Bob Casey (D-PA) and Sherrod Brown (D-OH) introduced what they deemed to be a legislative &quot;fix&quot; to the thorny...</description>
            <author>Cato-at-liberty</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4482744</comments>
            <pubDate>Tue, 15 Feb 2011 18:21:56 +0100</pubDate>
            <guid isPermaLink="false">4482744</guid>        </item>
        <item>
            <title>Congress: Where 20 Jobs = $580m</title>
            <link>http://www.medworm.com/index.php?rid=4349495&amp;cid=t_189691_87_f&amp;fid=36438&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FCato-at-liberty%2F%7E3%2Fsy63kPqOw_4%2F</link>
            <description>By Sallie JamesWhen talking to groups about the political economy of trade protection, I always mention concentrated benefits versus diffuse costs. Public choice theory explains many bad policies, of course, but tariffs and subsidies are excellent examples of interventions that benefit the few at the expense of the many.
Congress, or specifically two members of that esteemed body, have recently provided me with a textbook example. The Generalized System of Preferences is a federal program that offers duty-free access to the U.S. market to certain goods from certain developing countries. Or, I should say, was a federal program, because it expired on December 31. My opinion of the program is ambivalent at best, but one cannot deny that the program brings real cost savings to American consu...</description>
            <author>Cato-at-liberty</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4349495</comments>
            <pubDate>Fri, 14 Jan 2011 20:19:55 +0100</pubDate>
            <guid isPermaLink="false">4349495</guid>        </item>
        <item>
            <title>---</title>
            <link>http://www.medworm.com/index.php?rid=3746694&amp;cid=t_189691_87_f&amp;fid=34872&amp;url=http%3A%2F%2Fblisstree.com%2Ffeel%2F187105%2F</link>
            <description>Anxiety Leads to Heart Problems: A new study found that people with stable coronary heart disease and generalized anxiety disorder (GAD) had a higher rate of cardiovascular events than patients without GAD. (via ABC News)
Post from: BlissTree (Source: Healthbolt)</description>
            <author>Healthbolt</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3746694</comments>
            <pubDate>Tue, 06 Jul 2010 17:28:55 +0100</pubDate>
            <guid isPermaLink="false">3746694</guid>        </item>
        <item>
            <title>Scrambled brain connections linked to generalized anxiety disorder</title>
            <link>http://www.medworm.com/index.php?rid=3067128&amp;cid=t_189691_109_f&amp;fid=35671&amp;url=http%3A%2F%2Fwww.anxietyinsights.info%2Fgeneralized_anxiety_disorder_produces_distinct_brain_pattern.htm</link>
            <description>By Stephanie Pappas Stanford University School of Medicine Scrambled connections between the part of the brain that processes fear and emotion and other brain regions could be the hallmark of a common anxiety disorder, according to a new study from the Stanford University School of Medicine. The findings could help researchers identify biological differences between types of anxiety disorders as well as such disorders as depression. The study published in the Archives of General Psychiatry, examined the brains of people with generalized anxiety disorder, or GAD, a psychiatric condition in which patients spend their days in a haze of worry over everyday concerns. Researchers have known that the amygdala, a pair of almond-sized bundles of nerve fibers in the middle of the brain that help pro...</description>
            <author>Latest entries from www.anxietyinsights.info</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3067128</comments>
            <pubDate>Tue, 08 Dec 2009 08:10:00 +0100</pubDate>
            <guid isPermaLink="false">3067128</guid>        </item>
        <item>
            <title>Research-Backed Online Mental Health Interventions</title>
            <link>http://www.medworm.com/index.php?rid=2954554&amp;cid=t_189691_109_f&amp;fid=34750&amp;url=http%3A%2F%2Fpsychcentral.com%2Fblog%2Farchives%2F2009%2F11%2F02%2Fresearch-backed-online-mental-health-interventions%2F</link>
            <description>So the other week I attended and presented at the First International e-Mental Health Summit 2009 in Amsterdam and already discussed some great online interventions for depression.
I&amp;#8217;m still planning on talking about additional online interventions for other mental disorders, but am waiting for the conference folks to publish the presentations on their website because the abstract book doesn&amp;#8217;t always contain the valuable bits of information I need to properly summarize a topic area. 
In the meantime, I thought I&amp;#8217;d mention Beacon. Beacon is a website that has gone to the trouble of indexing and rating over 70 different online interventions in the following categories:

Alcohol (3/3)
  
Bipolar disorder (3/0)
  
Depression (24/11)
 
Eating disorder (anorexia or bulimia) (6/...</description>
            <author>World of Psychology</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2954554</comments>
            <pubDate>Mon, 02 Nov 2009 20:58:42 +0100</pubDate>
            <guid isPermaLink="false">2954554</guid>        </item>
        <item>
            <title>Prevalence of Common Mental Disorders</title>
            <link>http://www.medworm.com/index.php?rid=2862558&amp;cid=t_189691_109_f&amp;fid=34750&amp;url=http%3A%2F%2Fpsychcentral.com%2Fblog%2Farchives%2F2009%2F10%2F05%2Fprevalence-of-common-mental-disorders%2F</link>
            <description>In support of Mental Health Awareness Week &amp;#8212; meant to increase awareness of mental health issues and helping people better understand mental disorders &amp;#8212; we&amp;#8217;ve created the graph below to give you a better idea of the prevalence (in the past year) of these disorders in the general American population. The media sometimes emphasizes one disorder over another, distorting the picture of how many people actually have the disorder. For instance, the graph shows that bipolar disorder &amp;#8212; the subject of so many advertising campaigns, TV commercials and more &amp;#8212; has similar prevalence rates to panic disorder, generalized anxiety disorder (GAD), and binge eating. 
Mental disorders are more common than many people realize, and far fewer people seek out treatment for them than...</description>
            <author>World of Psychology</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2862558</comments>
            <pubDate>Mon, 05 Oct 2009 17:39:47 +0100</pubDate>
            <guid isPermaLink="false">2862558</guid>        </item>
        <item>
            <title>What is Anxiety?</title>
            <link>http://www.medworm.com/index.php?rid=2858666&amp;cid=t_189691_109_f&amp;fid=34750&amp;url=http%3A%2F%2Fpsychcentral.com%2Fblog%2Farchives%2F2009%2F10%2F04%2Fwhat-is-anxiety%2F</link>
            <description>Have you ever wondered what anxiety felt like?
Robin Marantz Henig, writing for The New York Times Magazine, has penned a great (but lengthy) piece about anxiety &amp;#8212; that non-specific feeling of nervousness that, for some, can be completely debilitating.
Anxiety differs from social phobia or other kinds of fears, because it isn&amp;#8217;t specific to particular situation (like speaking in front of crowds or going to a party). It can attack at any time, for any reason or no reason whatsoever. So while you or I may get butterflies in our stomach the first time before a big exam or presentation, someone with anxiety may have them virtually all of the time. 

Anxiety is not fear, exactly, because fear is focused on something right in front of you, a real and objective danger. It is instead a ...</description>
            <author>World of Psychology</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2858666</comments>
            <pubDate>Sun, 04 Oct 2009 18:25:53 +0100</pubDate>
            <guid isPermaLink="false">2858666</guid>        </item>
        <item>
            <title>Abstract: Extracellular serotonin level in the basolateral nucleus of the amygdala and dorsal periaqueductal gray under unconditioned and conditioned fear states</title>
            <link>http://www.medworm.com/index.php?rid=2685239&amp;cid=t_189691_109_f&amp;fid=35671&amp;url=http%3A%2F%2Fwww.anxietyinsights.info%2Fabstract_extracellular_serotonin_level_in_the_basolateral_n.htm</link>
            <description>Brain Res. 2009;doi:10.1016/j.brainres.2009.07.074 Extracellular serotonin level in the basolateral nucleus of the amygdala and dorsal periaqueductal gray under unconditioned and conditioned fear states: an in vivo microdialysis study Zanoveli JM, Carvalho MC, Cunha JM, Brand&amp;atilde;o ML. Serotonin (5-HT) plays a key role in the neural circuitry mediating unconditioned and conditioned fear responses related to panic and generalized anxiety disorders. The basolateral nucleus of the amygdala (BLA) and the dorsal periaqueductal gray (dPAG) appear to be mainly involved in these conditions. The aim of this study was to measure the extracellular level of 5-HT and its metabolite 5-hydroxyindolacetic acid (5-HIAA) in the BLA and dPAG during unconditioned and conditioned fear states using in vivo m...</description>
            <author>Latest entries from www.anxietyinsights.info</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2685239</comments>
            <pubDate>Mon, 10 Aug 2009 07:39:00 +0100</pubDate>
            <guid isPermaLink="false">2685239</guid>        </item>
        <item>
            <title>Swine Flu Anxiety</title>
            <link>http://www.medworm.com/index.php?rid=2660716&amp;cid=t_189691_87_f&amp;fid=36069&amp;url=http%3A%2F%2Ffrankiespeakingfrankly.blogspot.com%2F2009%2F07%2Fswine-flu-anxiety_20.html</link>
            <description>Honestly today I am soooo much better. I can now say for sure that I am disease free - still weak, but today I can actually say the coughing has stopped and each day I am feeling stronger. But last week I had one of the worst nights of my life. No joke, I really thought I was dying!As with most days over the past few weeks I woke feeling a little better, but in the afternoon my cough got worse and became very tiresome come the evening and into the night. This particular evening, feeling truly exhausted and in need of a good night's sleep, but unable to stop the coughing whenever I lay down, my husband gave me a sore throat sweet that included in it an anaesthetic to help relax my throat which he said had helped him.Indeed my throat muscles did relax, but then I started to feel really anxio...</description>
            <author>Frankie Speaking Frankly</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2660716</comments>
            <pubDate>Mon, 20 Jul 2009 22:18:00 +0100</pubDate>
            <guid isPermaLink="false">2660716</guid>        </item>
        <item>
            <title>Abstract: Effectiveness of mindfulness-based cognitive therapy as an adjuvant to pharmacotherapy in patients with panic disorder or generalized anxiety disorder</title>
            <link>http://www.medworm.com/index.php?rid=2561313&amp;cid=t_189691_109_f&amp;fid=35671&amp;url=http%3A%2F%2Fwww.anxietyinsights.info%2Fabstract_effectiveness_of_mindfulnessbased_cognitive_thera.htm</link>
            <description>Conclusions: MBCT may be effective at relieving anxiety and depressive symptoms in patients with panic disorder or generalized anxiety disorder. However, well-designed, randomized controlled trials are needed. (Text has been reformatted for online visual clarity, link added; ed.) Source... Copyright &amp;copy; 2009 Wiley-Liss, Inc., A Wiley Company (Source: Latest entries from www.anxietyinsights.info)</description>
            <author>Latest entries from www.anxietyinsights.info</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2561313</comments>
            <pubDate>Wed, 01 Jul 2009 07:47:00 +0100</pubDate>
            <guid isPermaLink="false">2561313</guid>        </item>
        <item>
            <title>Is valerian useful for relief of generalized anxiety?</title>
            <link>http://www.medworm.com/index.php?rid=2511063&amp;cid=t_189691_109_f&amp;fid=35671&amp;url=http%3A%2F%2Fwww.anxietyinsights.info%2Fis_valerian_useful_for_relief_of_generalized_anxiety.htm</link>
            <description>Written by Shamir Benji Anxiety disorders are quite common in our society. Anxiety can vary in intensity and can severely affect one's lifestyle. There are many medications available to treat anxiety but none is ideal and all of them have side effects. For this reason, many individuals with anxiety have now been turning to alternative health care for treatment of anxiety. One of the natural substances high highly recommended by the herbalist for anxiety is valerian. More... &amp;nbsp; &amp;nbsp; &amp;nbsp; Copyright &amp;copy; 2009 EmpowHer/HW Comment: &amp;nbsp;Benzodeiazepines are also &quot;natural substances.&quot; At least two of the commercial benzodiazepines, diazepam (Valium&amp;reg;) and lorazepam (Ativan&amp;reg;), occur in commonly eaten foods. See: Benzodiazepines naturally (Source: Latest entries from www.anxietyi...</description>
            <author>Latest entries from www.anxietyinsights.info</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2511063</comments>
            <pubDate>Mon, 22 Jun 2009 07:50:00 +0100</pubDate>
            <guid isPermaLink="false">2511063</guid>        </item>
        <item>
            <title>Abstract: Posttyphoon prevalence of PTSD, MDD, panic disorder, and GAD in a Vietnamese sample.</title>
            <link>http://www.medworm.com/index.php?rid=2441627&amp;cid=t_189691_109_f&amp;fid=35671&amp;url=http%3A%2F%2Fwww.anxietyinsights.info%2Fabstract_posttyphoon_prevalence_of_ptsd_mdd_panic_disorde.htm</link>
            <description>J Trauma Stress. 2009 May 19;doi:10.1002/jts.2040 Posttyphoon prevalence of posttraumatic stress disorder, major depressive disorder, panic disorder, and generalized anxiety disorder in a Vietnamese sample. Amstadter AB, Acierno R, Richardson LK, Kilpatrick DG, Gros DF, Gaboury MT, Tran TL, Trung LT, Tam NT, Tuan T, Buoi LT, Ha TT, Thach TD, Galea S. Medical University of South Carolina, Charleston, SC; Ralph H. Johnson Veterans Administration Medical Center, Charleston, SC; University of New Haven and Oskar Schindler Humanities Foundation, New Haven, CT; Health Department of Da Nang City, Da Nang City, Vietnam In 2006, typhoon Xangsane disrupted a multiagency health needs study of 4,982 individuals in Vietnam. Following this disaster, 798 of the original participants were reinterviewed to...</description>
            <author>Latest entries from www.anxietyinsights.info</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2441627</comments>
            <pubDate>Thu, 28 May 2009 07:44:00 +0100</pubDate>
            <guid isPermaLink="false">2441627</guid>        </item>
        <item>
            <title>Abstract: Pathways between nonmedical opioid use/dependence and psychiatric disorders</title>
            <link>http://www.medworm.com/index.php?rid=2441634&amp;cid=t_189691_109_f&amp;fid=35671&amp;url=http%3A%2F%2Fwww.anxietyinsights.info%2Fabstract_pathways_between_nonmedical_opioid_usedependence_.htm</link>
            <description>Conclusions: Our findings support a general vulnerability to nonmedical opioid use and major psychopathologies, as well as evidence for a 'self-medication' model for dependence resulting from nonmedical opioid use with bipolar disorder and generalized anxiety disorder. Source... &amp;copy; 2009 Elsevier Ireland Ltd. All rights reserved. (Source: Latest entries from www.anxietyinsights.info)</description>
            <author>Latest entries from www.anxietyinsights.info</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2441634</comments>
            <pubDate>Tue, 26 May 2009 07:42:00 +0100</pubDate>
            <guid isPermaLink="false">2441634</guid>        </item>
        <item>
            <title>Genes behind “Bearded Lady” Syndrome discovered</title>
            <link>http://www.medworm.com/index.php?rid=2442310&amp;cid=t_189691_131_f&amp;fid=34989&amp;url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FGeneticsHealth%2F%7E3%2Fzy4jy2NE4Io%2F</link>
            <description>Otherwise known as the Victorian Ape Woman, “Bearded Lady” Julia Pastrana was a circus act in 19th century Europe. Hers was an extremely rare genetic syndrome that baffled and fascinated the public since she was first exhibited by her husband.
Pastrana has a genetic syndrome known as hypertrichosis terminalis where straight coarse hair covered her entire face and body, and her teeth and gums were irregular.
&amp;quot;Bearded Lady&amp;quot; Julia Pastrana has rare genetic condition. Image: Public Domain

New research released Thursday uncovered the exact genetic mutation responsible for  conditions similar to Pastrana’s. Published in the May 12st issue of the American Journal of Human Genetics, the study looked into three large Chinese Han families with autosomal-dominant congenital generali...</description>
            <author>Genetics and Health</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2442310</comments>
            <pubDate>Fri, 22 May 2009 03:41:00 +0100</pubDate>
            <guid isPermaLink="false">2442310</guid>        </item>
        <item>
            <title>Abstract: Generalized anxiety disorder is associated with metabolic syndrome in the Vietnam experience study</title>
            <link>http://www.medworm.com/index.php?rid=2348466&amp;cid=t_189691_109_f&amp;fid=35671&amp;url=http%3A%2F%2Fwww.anxietyinsights.info%2Fabstract_generalized_anxiety_disorder_is_associated_with_me.htm</link>
            <description>Conclusions: Depression has very much been the focal condition for studies on mental health and physical health outcomes. The current data suggest that future research should perhaps pay equal attention to GAD. Source... Copyright &amp;copy; 2009 Society of Biological Psychiatry Published by Elsevier Inc. (Source: Latest entries from www.anxietyinsights.info)</description>
            <author>Latest entries from www.anxietyinsights.info</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2348466</comments>
            <pubDate>Thu, 16 Apr 2009 08:41:00 +0100</pubDate>
            <guid isPermaLink="false">2348466</guid>        </item>
        <item>
            <title>Abstract: Worry exposure versus applied relaxation in the treatment of GAD</title>
            <link>http://www.medworm.com/index.php?rid=2348475&amp;cid=t_189691_109_f&amp;fid=35671&amp;url=http%3A%2F%2Fwww.anxietyinsights.info%2Fabstract_worry_exposure_versus_applied_relaxation_in_the_tr.htm</link>
            <description>Conclusion: This is the first study to show that a stand-alone exposure in sensu technique - WE - is efficacious in the treatment of GAD. Both AR and WE seem to represent effective principles of change in GAD. Source... Copyright &amp;copy; 2009 S. Karger AG, Basel (Source: Latest entries from www.anxietyinsights.info)</description>
            <author>Latest entries from www.anxietyinsights.info</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2348475</comments>
            <pubDate>Tue, 14 Apr 2009 08:52:00 +0100</pubDate>
            <guid isPermaLink="false">2348475</guid>        </item>
        <item>
            <title>CBT helps elderly reduce worry improve mental health</title>
            <link>http://www.medworm.com/index.php?rid=2313420&amp;cid=t_189691_109_f&amp;fid=35671&amp;url=http%3A%2F%2Fwww.anxietyinsights.info%2Fcbt_helps_elderly_reduce_worry_improve_mental_health.htm</link>
            <description>This study is the first to suggest that CBT can be useful for managing worry and associated symptoms among older patients in primary care,&quot; the authors write. &quot;This study paves the way for future research to test sustainable models of care in more demographically heterogeneous groups.&quot; Stanley MA, Wilson NL, Novy DM, et al. Cognitive Behavior Therapy for Generalized Anxiety Disorder Among Older Adults in Primary Care: A Randomized Clinical Trial. JAMA. 2009 Apr 8;301(14):1460-1467 &amp;nbsp; [Abstract] (Source: Latest entries from www.anxietyinsights.info)</description>
            <author>Latest entries from www.anxietyinsights.info</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2313420</comments>
            <pubDate>Wed, 08 Apr 2009 08:59:00 +0100</pubDate>
            <guid isPermaLink="false">2313420</guid>        </item>
        <item>
            <title>Understanding Generalized Anxiety Disorder (pdf)</title>
            <link>http://www.medworm.com/index.php?rid=2258134&amp;cid=t_189691_109_f&amp;fid=35671&amp;url=http%3A%2F%2Fwww.anxietyinsights.info%2Flinkblog%2Fjump%2F%3Fi%3D509109</link>
            <description>An international mental health awareness packet providing accurate, evidence-based information about Generalized Anxiety Disorder -- its symptoms, its cultural differences, its treatment, and its impact on the lives of individuals who experience it and their families.

Produced by the World Federation for Mental Health (Source: Latest entries from www.anxietyinsights.info)</description>
            <author>Latest entries from www.anxietyinsights.info</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2258134</comments>
            <pubDate>Thu, 12 Mar 2009 00:15:00 +0100</pubDate>
            <guid isPermaLink="false">2258134</guid>        </item>
        <item>
            <title>SSRI antidepressants have moderate benefits for anxious elderly</title>
            <link>http://www.medworm.com/index.php?rid=2121956&amp;cid=t_189691_109_f&amp;fid=35671&amp;url=http%3A%2F%2Fwww.anxietyinsights.info%2Fssri_antidepressants_have_moderate_benefits_for_anxious_elde.htm</link>
            <description>Preliminary research suggests that use of the drug escitalopram (Lexapro&amp;reg;, Cipralex&amp;reg;) provided some improvement in symptoms for older adults with generalized anxiety disorder, although the overall benefits were diminished because of nonadherence to the drug by some patients, according to a study in the January 21 issue of JAMA. Generalized anxiety disorder (GAD), one of the most common psychiatric disorders in older adults, is defined by chronic, difficult-to-control worry and anxiety, with related symptoms such as muscle tension, sleep disturbance and fatigue. The prevalence of GAD is as high as 7.3 percent among community-dwelling older adults and even higher among primary care patients. Because the number of older adults in the U.S. is growing and there is a lack of effective tr...</description>
            <author>Latest entries from www.anxietyinsights.info</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2121956</comments>
            <pubDate>Wed, 21 Jan 2009 07:54:00 +0100</pubDate>
            <guid isPermaLink="false">2121956</guid>        </item>
        <item>
            <title>Abstract: Muscle tension in generalized anxiety disorder</title>
            <link>http://www.medworm.com/index.php?rid=2047545&amp;cid=t_189691_109_f&amp;fid=35671&amp;url=http%3A%2F%2Fwww.anxietyinsights.info%2Fabstract_muscle_tension_in_generalized_anxiety_disorder.htm</link>
            <description>Conclusions: Muscle tension in its objective and subjective representations may play a role in GAD through various pathways that are testable. Future research needs to better examine the different aspects and functions of muscle tension in GAD. Source... Copyright &amp;copy; 2008 Elsevier B.V. All rights reserved (Source: Latest entries from www.anxietyinsights.info)</description>
            <author>Latest entries from www.anxietyinsights.info</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2047545</comments>
            <pubDate>Thu, 18 Dec 2008 08:08:00 +0100</pubDate>
            <guid isPermaLink="false">2047545</guid>        </item>
        <item>
            <title>Free publication gives fresh perspectives on generalized anxiety disorder</title>
            <link>http://www.medworm.com/index.php?rid=1955423&amp;cid=t_189691_109_f&amp;fid=35671&amp;url=http%3A%2F%2Fwww.anxietyinsights.info%2Ffree_publication_gives_fresh_perspectives_on_generalised_anx.htm</link>
            <description>The World Federation for Mental Health (WFMH) has published a comprehensive 40 page toolkit &quot;Understanding generalized anxiety disorder&quot; to help people understand this debilitating disorder. The publication provides up-to date information about generalized anxiety disorder (GAD) in both adults and children, its current treatments, and the effects of stigma on those living with the disorder. Through the information presented, the toolkit aims to educate and inform those with GAD, their physicians, families and friends, and the general public about a condition that affects the lives of millions of people, and results in marked disability and significantly impaired quality of life. In addition to the information about GAD, the toolkit also contains a list of national and local organization wh...</description>
            <author>Latest entries from www.anxietyinsights.info</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1955423</comments>
            <pubDate>Thu, 13 Nov 2008 08:12:00 +0100</pubDate>
            <guid isPermaLink="false">1955423</guid>        </item>
        <item>
            <title>Olympian Kristin Armstrong signed photo - Give-away!</title>
            <link>http://www.medworm.com/index.php?rid=1947256&amp;cid=t_189691_131_f&amp;fid=34989&amp;url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FGeneticsHealth%2F%7E3%2F094EeiwySCQ%2F</link>
            <description>Kristin Armstrong jokes that she is NOT related to cyclist Lance Armstrong or to his first wife with the same name (she&amp;#8217;s really not), but she and Lance does have something in common - cycling and medal. Kristin won gold medal in Women&amp;#8217;s Timed Trial in cycling at Beijing Olympics. She&amp;#8217;s also known for suffering from osteoarthritis, while under training! 
Osteoarthritis (OA) has major genetic component, but it is complex and not completely understood. A large, multi-center genetic study of generalized osteoarthritis has recently started. There was suggestion of association between short height and osteoarthritis, and mutation in the collagen gene, but clearly, lifestyle is a major factor in developing the disease. 
Kristin is a huge advocate of the importance and benefits ...</description>
            <author>Genetics and Health</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1947256</comments>
            <pubDate>Tue, 11 Nov 2008 04:57:05 +0100</pubDate>
            <guid isPermaLink="false">1947256</guid>        </item>
        <item>
            <title>Abstract: Efficacy and safety of pregabalin in elderly people with generalised anxiety disorder</title>
            <link>http://www.medworm.com/index.php?rid=1927901&amp;cid=t_189691_109_f&amp;fid=35671&amp;url=http%3A%2F%2Fwww.anxietyinsights.info%2Fabstract_efficacy_and_safety_of_pregabalin_in_elderly_peopl.htm</link>
            <description>Conclusions: Pregabalin, in doses of 150-600 mg/day, was a safe and effective treatment of generalised anxiety disorder in patients 65 years and older. The anxiolytic efficacy of pregabalin had an early onset (by 2 weeks) and significantly improved both psychic and somatic symptoms of anxiety. Source... &amp;copy; 2008 The Royal College of Psychiatrists (Source: Latest entries from www.anxietyinsights.info)</description>
            <author>Latest entries from www.anxietyinsights.info</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1927901</comments>
            <pubDate>Mon, 03 Nov 2008 08:01:00 +0100</pubDate>
            <guid isPermaLink="false">1927901</guid>        </item>
        <item>
            <title>Abstract: Evaluation of the effectiveness of crenotherapy in treating generalized anxiety disorder</title>
            <link>http://www.medworm.com/index.php?rid=1726562&amp;cid=t_189691_109_f&amp;fid=35671&amp;url=http%3A%2F%2Fwww.anxietyinsights.info%2Fabstract_evaluation_of_the_effectiveness_of_crenotherapy_in.htm</link>
            <description>Sante Publique. 2008 Mar-Apr;20(2):105-12. Evaluation of the effectiveness of crenotherapy in treating generalized anxiety disorder Salamon R, Christine G, Oli&amp;eacute; JP, Dubois O. INSERM U 593, 146, rue Leo-Saignat, 33076 Bordeaux Cedex, France. [Article in French] In preliminary studies, crenotherapy has emerged as a possible effective treatment for general anxiety disorder. We have compared crenotherapy to Paroxetine [Paxil&amp;reg;] in a randomized multicentric control trial for a period of 8 weeks. 237 patients who met the diagnosis criteria of generalized anxiety disorder (DSM-IV) were recruited, 117 patients were randomly assigned to Crenotherapy and 120 to Paroxetine. Evaluation of effectiveness was assessed using the scoring system according to the Hamilton Rating Scale for Anxiety (...</description>
            <author>Latest entries from www.anxietyinsights.info</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1726562</comments>
            <pubDate>Sat, 23 Aug 2008 08:06:00 +0100</pubDate>
            <guid isPermaLink="false">1726562</guid>        </item>
        <item>
            <title>Pregabalin for Generalized Anxiety Disorder</title>
            <link>http://www.medworm.com/index.php?rid=1714097&amp;cid=t_189691_109_f&amp;fid=35671&amp;url=http%3A%2F%2Fwww.anxietyinsights.info%2Fpregabalin_for_generalized_anxiety_disorder.htm</link>
            <description>Leard-Hansson J, Guttmacher L.The Problem You have a patient with generalized anxiety disorder who previously has been treated with selective serotonin reuptake inhibitors, selective norepinephrine reuptake inhibitors, and buspirone with inadequate relief. In an attempt to avoid a benzodiazepine, you consider pregabalin (Lyrica). The Question Is pregabalin effective in treating GAD? The Analysis We performed a Medline search combining &quot;pregabalin&quot; and &quot;anxiety.&quot;The Evidence Pregabalin is an alpha2-delta voltage-gated calcium channel blocker that reduces the release of excitatory neurotransmitters. It has Food and Drug Administration approval for diabetic peripheral neuropathic pain, postherpetic neuralgia, adjunctive treatment in partial-onset seizures, and fibromyalgia. More... &amp;copy; 200...</description>
            <author>Latest entries from www.anxietyinsights.info</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1714097</comments>
            <pubDate>Tue, 19 Aug 2008 08:34:00 +0100</pubDate>
            <guid isPermaLink="false">1714097</guid>        </item>
        <item>
            <title>Help!  I’m Anxious about My Anxiety Management Class!</title>
            <link>http://www.medworm.com/index.php?rid=1556287&amp;cid=t_189691_109_f&amp;fid=34750&amp;url=http%3A%2F%2Fpsychcentral.com%2Fblog%2Farchives%2F2008%2F06%2F30%2Fhelp-im-anxious-about-my-anxiety-management-class%2F</link>
            <description>Pages: 1 2 Next &amp;raquo; &amp;nbsp;&amp;nbsp;&amp;nbsp; Single Page 	I took a seat at a large conference table in the university’s counseling center. I looked around nervously. I kept my hands in my lap, fingers (figuratively) crossed, hoping that I wouldn’t recognize a single face that walked through the door and into the Anxiety and Stress Management Class that I’d signed up for. It was a six-week class that I’d discovered via a flier posted on a bulletin board outside of my second home, the university library. As I sat and waited, my heartbeat felt large and uncomfortable. No doubt, I was anxious. 
	I was a first-semester graduate student at the time, trying to keep up with the 200+ pages I needed to read each week for my classes. It was just too much reading. (I hadn’t yet fully realized ...</description>
            <author>World of Psychology</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1556287</comments>
            <pubDate>Mon, 30 Jun 2008 17:21:19 +0100</pubDate>
            <guid isPermaLink="false">1556287</guid>        </item>
        <item>
            <title>Abstract+: Duration of untreated illness as a predictor of treatment response and clinical course in GAD</title>
            <link>http://www.medworm.com/index.php?rid=1437075&amp;cid=t_189691_109_f&amp;fid=35671&amp;url=http%3A%2F%2Fwww.anxietyinsights.info%2Fabstract_duration_of_untreated_illness_as_a_predictor_of_t.htm</link>
            <description>Conclusion: Results from this preliminary study seem to suggest that a shorter DUI-AD may determine a better response to pharmacologic treatment in patients with GAD, and that a longer DUI (DUI-BDZ and DUI-AD) may be associated to a worse clinical course. Further investigation on the relationship between DUI and GAD is needed. Source + Full text... (Source: Latest entries from www.anxietyinsights.info)</description>
            <author>Latest entries from www.anxietyinsights.info</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1437075</comments>
            <pubDate>Mon, 12 May 2008 08:21:00 +0100</pubDate>
            <guid isPermaLink="false">1437075</guid>        </item>
        <item>
            <title>Abstract+: The potential of virtual reality as anxiety management tool</title>
            <link>http://www.medworm.com/index.php?rid=1423632&amp;cid=t_189691_109_f&amp;fid=35671&amp;url=http%3A%2F%2Fwww.anxietyinsights.info%2Fabstract_the_potential_of_virtual_reality_as_anxiety_manag.htm</link>
            <description>Conclusion: We argue that the use of VR for relaxation represents a promising approach in the treatment of GAD since it enhances the quality of the relaxing experience through the elicitation of the sense of presence. This controlled trial will evaluate the effects of the use of VR in relaxation while preserving the benefits of randomization to reduce bias. Trial Registration: NCT00602212 (ClinicalTrials.gov) (Text has been reformatted for clarity; ed.) Source | Full text () (Source: Latest entries from www.anxietyinsights.info)</description>
            <author>Latest entries from www.anxietyinsights.info</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1423632</comments>
            <pubDate>Tue, 06 May 2008 08:03:00 +0100</pubDate>
            <guid isPermaLink="false">1423632</guid>        </item>
        <item>
            <title>Abstract: Mindfulness-based cognitive therapy for generalized anxiety disorder</title>
            <link>http://www.medworm.com/index.php?rid=1369750&amp;cid=t_189691_109_f&amp;fid=35671&amp;url=http%3A%2F%2Fwww.anxietyinsights.info%2Fabstract_mindfulnessbased_cognitive_therapy_for_generalize.htm</link>
            <description>Conclusion: MBCT may be an acceptable and potentially effective treatment for reducing anxiety and mood symptoms and increasing awareness of everyday experiences in patients with GAD. Future directions include development of a randomized clinical trial of MBCT for GAD. Source... (Source: Latest entries from www.anxietyinsights.info)</description>
            <author>Latest entries from www.anxietyinsights.info</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1369750</comments>
            <pubDate>Mon, 14 Apr 2008 07:03:00 +0100</pubDate>
            <guid isPermaLink="false">1369750</guid>        </item>
        <item>
            <title>GAD anxiety symptoms reduced by cranial stimulation</title>
            <link>http://www.medworm.com/index.php?rid=1358615&amp;cid=t_189691_109_f&amp;fid=35671&amp;url=http%3A%2F%2Fwww.anxietyinsights.info%2Fgad_anxiety_symptoms_reduced_by_cranial_stimulation.htm</link>
            <description>MedWire News: Cranial electrotherapy stimulation (CES) appears to reduce symptoms of anxiety in patients with generalized anxiety disorder (GAD), say US scientists. CES has been used for many years to treat anxiety, depression, and insomnia in the general population. However, its role in the treatment of GAD has not been examined, explain Alexander Bystritsky and colleagues from the University of California at Los Angeles. More... &amp;copy; AstraZeneca 2008 (Source: Latest entries from www.anxietyinsights.info)</description>
            <author>Latest entries from www.anxietyinsights.info</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1358615</comments>
            <pubDate>Wed, 09 Apr 2008 08:32:00 +0100</pubDate>
            <guid isPermaLink="false">1358615</guid>        </item>
        <item>
            <title>Differences between MDE [major depressive episode] and GAD [generalized anxiety disorder] uncovered</title>
            <link>http://www.medworm.com/index.php?rid=1279505&amp;cid=t_189691_109_f&amp;fid=35671&amp;url=http%3A%2F%2Fwww.anxietyinsights.info%2Fdifferences_between_mde_major_depressive_episode_and_gad_.htm</link>
            <description>MedWire News: Generalized anxiety disorder (GAD) and major depressive episode (MDE) differ in their risk factors, say US scientists, who add that the findings undermine the notion that they are manifestations of a single underlying syndrome. Previous studies have demonstrated that GAD and MDE are highly comorbid. More... &amp;copy;Current Medicine Group Ltd (Source: Latest entries from www.anxietyinsights.info)</description>
            <author>Latest entries from www.anxietyinsights.info</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1279505</comments>
            <pubDate>Wed, 05 Mar 2008 07:18:00 +0100</pubDate>
            <guid isPermaLink="false">1279505</guid>        </item>
        <item>
            <title>Abstract:  Use of benzodiazepines and SSRIs in middle-aged and older adults with anxiety disorders</title>
            <link>http://www.medworm.com/index.php?rid=1150756&amp;cid=t_189691_109_f&amp;fid=35671&amp;url=http%3A%2F%2Fwww.anxietyinsights.info%2Fabstract__use_of_benzodiazepines_and_ssris_in_middleaged_a.htm</link>
            <description>Conclusions: Although there was an increase in SSRI/SNRI use in older participants with anxiety disorders over the course of study, at nine years of follow-up, only 35% of participants were utilizing SSRI/SNRI medication, while more than one-half of the same participants were continuing to use BZs. To the authors' knowledge, there are no randomized clinical trials that have addressed comparative efficacy and safety of BZs and SSRIs/SNRIs in this population. However, there is documented evidence of adverse effects of chronic BZ use and the risk of developing dependency in older populations. Source... (Source: Latest entries from www.anxietyinsights.info)</description>
            <author>Latest entries from www.anxietyinsights.info</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1150756</comments>
            <pubDate>Tue, 15 Jan 2008 06:20:00 +0100</pubDate>
            <guid isPermaLink="false">1150756</guid>        </item>
        <item>
            <title>Seroquel for Everything and Academic Spokespeople</title>
            <link>http://www.medworm.com/index.php?rid=1074948&amp;cid=t_189691_109_f&amp;fid=34800&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FClinicalPsychologyAndPsychiatryACloserLook%2F%7E3%2F196112173%2Fseroquel-for-everything-and-academic.html</link>
            <description>Part 1. Seroquel for Depression and Anxiety. AstraZeneca is slowly rolling out the PR for Seroquel as a treatment for depression and generalized anxiety disorder. At something called the 7th International Forum on Mood and Anxiety Disorders, AstraZeneca (via academic frontman Stuart Montgomery) has trotted out data from their latest clinical trials which purportedly show that Seroquel beat placebo for depression and GAD. Here's a quote from the detached, independent, non-conflicted academic author, Stuart Montgomery...Dr. Stuart Montgomery, Imperial College School of Medicine, University of London and author of the [depression] monotherapy study, said: These study results are remarkable -- all of the doses of SEROQUEL XR examined provided improvements in MDD and GAD symptoms. Results from ...</description>
            <author>Clinical Psychology and Psychiatry: A Closer Look</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1074948</comments>
            <pubDate>Thu, 06 Dec 2007 14:25:00 +0100</pubDate>
            <guid isPermaLink="false">1074948</guid>        </item>
        <item>
            <title>Generalized Anxiety Disorder - Patient treatment manual (pdf)</title>
            <link>http://www.medworm.com/index.php?rid=1060138&amp;cid=t_189691_109_f&amp;fid=35671&amp;url=http%3A%2F%2Fwww.anxietyinsights.info%2Flinkblog%2Fjump%2F%3Fi%3D500315</link>
            <description>This manual is both a guide to treatment and a workbook for persons who suffer from generalized anxiety disorder. During treatment, it is a workbook in which individuals can record their own experience of their disorder, together with the additional advice for their particular case given by their clinician. After treatment has concluded, this manual will serve as a self-help resource enabling those who have recovered, but who encounter further stress or difficulties, to read the appropriate section and, by putting the content into action, stay well.

Produced by Clinical Research Unit for Anxiety Disorders
St. Vincent’s Hospital, Sydney, Australia (Source: Latest entries from www.anxietyinsights.info)</description>
            <author>Latest entries from www.anxietyinsights.info</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1060138</comments>
            <pubDate>Thu, 29 Nov 2007 22:59:00 +0100</pubDate>
            <guid isPermaLink="false">1060138</guid>        </item>
        <item>
            <title>Abstract:  Pregabalin: Its efficacy, safety and tolerability profile in generalized anxiety.</title>
            <link>http://www.medworm.com/index.php?rid=968437&amp;cid=t_189691_109_f&amp;fid=35671&amp;url=http%3A%2F%2Fwww.anxietyinsights.info%2Fabstract__pregabalin_its_efficacy_safety_and_tolerability.htm</link>
            <description>Drugs Today (Barc). 2007 Sep;43(9):601-10 Pregabalin: Its efficacy, safety and tolerability profile in generalized anxiety. Owen RT.Medical Information Department, Prous Science, Barcelona, Spain. Pregabalin is a structural analogue of gammaaminobutyric acid (GABA), one of the key inhibitory neurotransmitters in the brain. Its mode of action is believed to be mediated by the alpha-2-delta-1 subunit protein of voltage-gated calcium channels to bring about its anxiolytic, anticonvulsant and antinociceptive effects. Pregabalin has linear pharmacokinetics, undergoes minimal metabolism and is excreted largely unchanged. It has a mean elimination half-life of 6.3 hours. Pregabalin's anxiolytic activity in generalized anxiety disorder has been demonstrated in seven acute randomized, doubleblind, ...</description>
            <author>Latest entries from www.anxietyinsights.info</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=968437</comments>
            <pubDate>Mon, 22 Oct 2007 06:38:00 +0100</pubDate>
            <guid isPermaLink="false">968437</guid>        </item>
        <item>
            <title>Abstract: Comparisons of psychopharmacological and psychological treatments for anxiety disorders</title>
            <link>http://www.medworm.com/index.php?rid=904621&amp;cid=t_189691_109_f&amp;fid=35671&amp;url=http%3A%2F%2Fwww.anxietyinsights.info%2Fabstract_comparisons_of_psychopharmacological_and_psycholog.htm</link>
            <description>Conclusions: While drug treatment and CBT showed equal efficacy, only in panic disorder the combination of pharmacological and psychological treatment was superior to either treatment alone. For the other anxiety disorders, the evidence for greater efficacy of combination treatment is still not sufficient due to lack of studies. (Text has been reformatted for clarity; ed.) Source... (Source: Latest entries from www.anxietyinsights.info)</description>
            <author>Latest entries from www.anxietyinsights.info</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=904621</comments>
            <pubDate>Wed, 26 Sep 2007 08:55:00 +0100</pubDate>
            <guid isPermaLink="false">904621</guid>        </item>
        <item>
            <title>Abstract: Benzodiazepines in generalized anxiety disorder</title>
            <link>http://www.medworm.com/index.php?rid=894327&amp;cid=t_189691_109_f&amp;fid=35671&amp;url=http%3A%2F%2Fwww.anxietyinsights.info%2Fabstract_benzodiazepines_in_generalized_anxiety_disorder.htm</link>
            <description>The objective of this study was to assess the effectiveness and efficacy of benzodiazepines in the treatment of GAD based on trial drop-out rates. We used a systematic review of randomized controlled trials that compared any of the three best established benzodiazepines (diazepam, Lorazepam and aLprazolam) against placebo. Our primary outcome for effectiveness was withdrawal for any reason. Our secondary outcome tapping efficacy was withdrawal due to lack of efficacy, and that tapping side effects was withdrawals due to adverse events. We included 23 trials. Pooled analysis indicated less risk of treatment discontinuation due to lack of efficacy for benzodiazepines, compared to placebo, relative risk (RR) 0.29 (95% CI 0.18-0.45; p &amp;lt; 0.00001). Nevertheless, pooled analysis showed no conc...</description>
            <author>Latest entries from www.anxietyinsights.info</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=894327</comments>
            <pubDate>Mon, 24 Sep 2007 08:31:00 +0100</pubDate>
            <guid isPermaLink="false">894327</guid>        </item>
        <item>
            <title>Abstract: CBT &amp; relaxation therapy equally effective for GAD, but CBT better for panic</title>
            <link>http://www.medworm.com/index.php?rid=786981&amp;cid=t_189691_109_f&amp;fid=35671&amp;url=http%3A%2F%2Fwww.anxietyinsights.info%2Fabstract_cbt_amp_relaxation_therapy_equally_effective_for.htm</link>
            <description>J Consult Clin Psychol. 2007 Aug;75(4):513-22. Specificity of treatment effects: Cognitive therapy and relaxation for generalized anxiety and panic disorders. Siev J, Chambless DL. Department of PsychologyUniversity of Pennsylvania, Philadelphia, PA, US. &amp;#106;&amp;#115;&amp;#105;&amp;#101;&amp;#118;&amp;#64;&amp;#112;&amp;#115;&amp;#121;&amp;#99;&amp;#104;&amp;#46;&amp;#117;&amp;#112;&amp;#101;&amp;#110;&amp;#110;&amp;#46;&amp;#101;&amp;#100;&amp;#117;. The aim of this study was to address claims that among bona fide treatments no one is more efficacious than another by comparing the relative efficacy of cognitive therapy (CT) and relaxation therapy (RT) in the treatment of generalized anxiety disorder (GAD) and panic disorder without agoraphobia (PD). Two fixed-effects meta-analyses were conducted, for GAD and PD separately, to review the treatment outcome literatur...</description>
            <author>Latest entries from www.anxietyinsights.info</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=786981</comments>
            <pubDate>Wed, 08 Aug 2007 08:56:00 +0100</pubDate>
            <guid isPermaLink="false">786981</guid>        </item>
        <item>
            <title>Abstract: Pregabalin for the treatment of generalized anxiety disorder</title>
            <link>http://www.medworm.com/index.php?rid=720107&amp;cid=t_189691_109_f&amp;fid=35671&amp;url=http%3A%2F%2Fwww.anxietyinsights.info%2Fabstract_pregabalin_for_the_treatment_of_generalized_anxiet.htm</link>
            <description>Expert Rev Neurother. 2007 Jul; 7(7): 769-81; Pregabalin for the treatment of generalized anxiety disorder: a novel pharmacologic intervention. Bandelow B, Wedekind D, Leon T. University of G&amp;ouml;ttingen, Department of Psychiatry &amp; Psychotherapy, von-Siebold-Str. 5, D-37075 G&amp;ouml;ttingen, Germany. &amp;#115;&amp;#101;&amp;#107;&amp;#114;&amp;#101;&amp;#116;&amp;#97;&amp;#114;&amp;#105;&amp;#97;&amp;#116;&amp;#46;&amp;#98;&amp;#97;&amp;#110;&amp;#100;&amp;#101;&amp;#108;&amp;#111;&amp;#119;&amp;#64;&amp;#109;&amp;#101;&amp;#100;&amp;#105;&amp;#122;&amp;#105;&amp;#110;&amp;#46;&amp;#117;&amp;#110;&amp;#105;&amp;#45;&amp;#103;&amp;#111;&amp;#101;&amp;#116;&amp;#116;&amp;#105;&amp;#110;&amp;#103;&amp;#101;&amp;#110;&amp;#46;&amp;#100;&amp;#101; Pregabalin [Lyrica&amp;reg;] is the first anxiolytic pharmacologic alternative for the treatment of generalized anxiety disorder (GAD) to be introduced in more than 10 years. GAD is a significant psychiatric condition with lifetime...</description>
            <author>Latest entries from www.anxietyinsights.info</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=720107</comments>
            <pubDate>Sun, 08 Jul 2007 08:25:00 +0100</pubDate>
            <guid isPermaLink="false">720107</guid>        </item>
        <item>
            <title>Abstract: A family study of co-morbidity between social phobia and GAD</title>
            <link>http://www.medworm.com/index.php?rid=655715&amp;cid=t_189691_109_f&amp;fid=35671&amp;url=http%3A%2F%2Fwww.anxietyinsights.info%2Fabstract_a_family_study_of_comorbidity_between_social_phob.htm</link>
            <description>Conclusions: The results were most consistent with a co-morbidity model indicating independent familial transmission of GSP and GAD. This has clinical implications for the treatment of patients with both disorders. Source... (Source: Latest entries from www.anxietyinsights.info)</description>
            <author>Latest entries from www.anxietyinsights.info</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=655715</comments>
            <pubDate>Mon, 04 Jun 2007 08:46:00 +0100</pubDate>
            <guid isPermaLink="false">655715</guid>        </item>
        <item>
            <title>A Soldier's Perspective: PTSD</title>
            <link>http://www.medworm.com/index.php?rid=4060866&amp;cid=t_189691_109_f&amp;fid=34859&amp;url=http%3A%2F%2Fblog.davemsw.com%2Farchives%2F2005%2F10%2Fa_soldiers_perspective_ptsd.php</link>
            <description>Boston Globe

IRAQ VETERAN Daniel Cotnoir learned that Baghdad rules don't apply in Lawrence (Mass.). The former Marine sergeant, who was named 2005's ''Marine of the Year&quot; by the Marine Corps Times newspaper, was charged earlier this month with two counts of armed assault with intent to murder after firing a shotgun near a crowd of revelers outside his home. He had already reported their noise to police and, when a glass bottle shattered his bedroom window, Cotnoir allegedly feared for the safety of his wife and children. 

As a Marine officer from 1999 to 2003, I led platoons in Afghanistan and Iraq. Following two combat tours, I left active duty to go to graduate school, thinking I could seamlessly return to normal life. But even with a loving family, supportive friends, and solid futur...</description>
            <author>Ψ Dare To Dream...</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4060866</comments>
            <pubDate>Sun, 30 Oct 2005 21:06:44 +0100</pubDate>
            <guid isPermaLink="false">4060866</guid>        </item>
    </channel>
</rss>

